Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Nanalysis Scientific Corp NSCIF


Primary Symbol: V.NSCI

Healthcare Technology Medical Devices Scientific & Technical Instruments
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100... see more

Recent & Breaking News (TSXV:NSCI)

Nanalysis Announces First Quarter 2026 Results

Canada NewsWire 11 hours ago

Nanalysis Announces First Quarter 2026 Conference Call

Canada NewsWire 7 days ago

Nanalysis Announces Board Transition and Appointment of Three New Directors

Canada NewsWire May 1, 2026

Nanalysis Announces Fourth Quarter and Full Year 2025 Results

Canada NewsWire April 8, 2026

Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call

Canada NewsWire April 2, 2026

Nanalysis Announces Grant of Options and Restricted Share Units

Canada NewsWire March 4, 2026

Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering

Canada NewsWire January 26, 2026

Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche

Canada NewsWire December 23, 2025

Nanalysis Announces $2.5 Million Private Placement

PR Newswire December 8, 2025

Nanalysis Announces Third Quarter 2025 Results

PR Newswire November 24, 2025

Nanalysis Announces Third Quarter 2025 Conference Call

PR Newswire November 18, 2025

Nanalysis Announces Change of Management

PR Newswire November 14, 2025

Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026

PR Newswire October 7, 2025

Nanalysis Chosen by IMRIS as Critical Component MRI Supplier

PR Newswire September 3, 2025

Nanalysis Announces Second Quarter 2025 Results

PR Newswire August 28, 2025

Nanalysis Announces Second Quarter 2025 Conference Call

Canada NewsWire August 21, 2025

Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro)

PR Newswire July 9, 2025

Nanalysis Announces Closing of Fully Subscribed Note Offering

Canada NewsWire June 13, 2025

Nanalysis Announces Fully Subscribed $2 Million Note Offering

Canada NewsWire June 6, 2025

Nanalysis Announces Note Offering of $2 Million

Canada NewsWire June 6, 2025

Podcasts